• 00D
  • 00H
  • 00M
  • 00S
Sponsorship Opportunities
Search

UroGP 2024

2024 Program

UroGP 2024
0755 – 0800
Welcome by conveners
Prof Damien Bolton & Prof Nathan Lawrentschuk
0800 – 0820
Active surveillance in prostate cancer – GP involvement and role
Prof Nathan Lawrentschuk
0820 – 0840
Surgical treatment options for BPH and the post-operative care in the community and Q&A
Prof Damien Bolton
0840 – 0900
PSA testing: who needs what test and when?
Dr Anthony Ta
0900 – 0915
Demystifying prostate MRIs – case presentations
Mr Bradley Newell
0915 – 0930
New urological therapies seen in the community: Discussion and quiz
A/Prof Joseph Ischia
0930 – 950
Urological dermatology for the GP; A Case-by-case Evaluation Scenario
Dr Isaac Lee
0950 – 1015
Morning tea with industry
1015 – 1030
Testicular Cancer – Red Flags and What To Do?
Mr Dixon Woon
1030 – 1045
Haematuria workup in the community: what investigations to order and when? Case analyses with GP participation
Mr Peter Liodakis
1045 – 1105
Kidney lesions – which ones need what treatment?
Mr Yee Chan
1105 – 1125
Medical therapies you can prescribe for incontinence
Dr Jos Jayarajan
1125 – 1140
GP led management of urinary stones – case-based discussions
Mr Greg Jack
1140 – 1155
New medical therapies in BPH for the GP
Dr Renu Eapen
1155 – 1210
Prostate cancer radiation therapy in 2024
Prof Michael Chao
1210 – 1230
Robot assisted surgeries: what is it and commonly asked questions
Mr Nieroshan Rajarubendrah
1230 – 1300
Lunch with exhibitors
1300 – 1315
Physiotherapy for pelvic pain and incontinence: what it is and how to counsel your patients
Ms Tafy Seade
1315 – 1335
Bladder Cancer and the GP involvement: Case Presentations and Interactive Discussion
Prof Nathan Lawrentschuk
1335 – 1350
Case discussion: GP led management of recurrent urinary tract infections?
Dr Sandra Elmer
1350 – 1410
Vasectomy and its reversal – tips on patient counselling
Mr Andrew Troy
1410 – 1430
Slings and Neuromodulation for Urinary Incontinence – Problems and Solutions?
A/Prof Johan Gani
1430 – 1450
Erectile dysfunction in General Practice
Dr Kapil Sethi
1450 – 1500
Final Question and Answer session plus Case examples
Prof Nathan Lawrentschuk
1500 – 1505
Closing remarks
Prof Damien Bolton & Prof Nathan Lawrentschuk
1505 – 1605
Research presentations in conjunction with YURO

2024 Sponsors and Exhibitors

Gold Sponsor
GenesisCare_300x300.png
Silver Sponsors
AstraZeneca_300x300.png
Bayer
Ipsen_300x300.png
UroGP24 Dorevitch | Lumus
Mayne Pharma
Astellas 300x300
Boston Scientific_300x300
Catering Sponsor
Device Technologies_300x300 (1)
Exhibitors
ABOUT
PROGRAM
SPONSORS & EXHIBITORS
MAILING LIST

Keep up to date with the latest from UroGP

Join mailing list

Copyright 2021-2025 © UroGP. All rights reserved.

Designed and built by MCI Australia

GenesisCare

GenesisCare is an Australian based global company
We have more than 440 centres to help us bring the right care to our patients. For radiotherapy, that includes 14 centres in the UK, 21 in Spain, 36 in Australia and 300 in the U.S. We also offer cardiology and sleep services at more than 80 locations across Australia. Every year our team sees more than 400,000 people globally.

We work to develop detailed understanding of patient needs to design the right care plan whether being treated for cancer, heart disease or sleep disorders.

There are seven GenesisCare radiotherapy centres in the Melbourne Metro region.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.

The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit: www.astrazeneca.com

Bayer

Bayer is a global life science company with expertise in healthcare and agriculture. Guided by our purpose, Science For A Better Life, Bayer has been making a positive difference to the lives of Australians since 1925. As people live longer and the population continues to grow, Bayer is one of the few companies that takes a comprehensive view of these issues. We apply our global scientific expertise in healthcare and agriculture to deliver innovations locally to help people and the planet thrive.

Approval number: PP-NUB-AU-0101-1
Date of preparation: August 2021

Ipsen

Ipsen provides specialty medicines and quality services to Healthcare Professional and their patients suffering from debilitating diseases.

At Ipsen, our passion is improving the lives of patients. We do this by working together to build partnerships based on trust and mutual respect with Healthcare Professionals. We deliver tailored solutions through our agility and innovation and we strive to be even better tomorrow than we are today.

Ipsen Pty Ltd is the Australian affiliate of a global biotech company.

Mayne Pharma

Mayne Pharma offers two Urology products in Australia: 

Urorec® (silodosin)- highly selective alpha blocker for relief of lower urinary tracts symptoms associated with BPH. 

Monurol® (fosfomycin trometamol)- single dose oral antibiotic approved for treatment of uncomplicated lower UTI in females over 12 years. 

Contact diana.krasnopeeva@maynepharma.com or au.enquiries@maynepharma.com 

Mundipharma

Mundipharma is a healthcare company that provides healthcare products to Australians to enable them to live well and age well. We improve patients’ lives in meaningful ways by providing effective therapies along with educational resources that support their proper use. Mundipharma Australia is a member of a global network of independent associated companies which are engaged in research, development, production and marketing of prescription medicines and healthcare products. Our areas of expertise in ethical medicine include pain, oncology, respiratory disease, and ophthalmology.

Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. We are anchored in our commitment to clinician education to support the evolving needs of the urological community. Boston Scientific offers a range of solutions for the treatment of kidney stones, benign prostatic hyperplasia (BPH), erectile dysfunction (ED), male incontinence and pelvic floor disorders.

Lumus Imaging

For many years, Healthcare Imaging Services have operated under multiple brand names across Australia to provide a variety of imaging services to our patients, referrers, suppliers, and partners. As we continue to support our aim to be a customer-centric healthcare business, we have unified all our Health Care Imaging Services brands under one national brand, Lumus Imaging®. Lumus Imaging harnesses all of our knowledge and expertise and combines it with the empathy and care of our people. 

In addition to refreshing our brand identity across our 135 site nationally, Lumus Imaging is updating services, focusing on digital capabilities, and enhancing the way the business interacts with its patients and referrers. No matter where you are or what you need, at Lumus Imaging, we are here to provide you with the knowledge that matters by people that care.

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Facebook Twitter Linkedin Youtube Instagram